KOSDAQ · Healthcare · ₩49B
₩2,645-3.82%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.4% · as of 26.10.27
Among 37 신약 개발 peers
Quarterly Revenue Growth
“신약 후보의 사업화가 이어지며 다음 도약을 준비해요.”
In the company's words · 2026 2분기 filing